BARTLETT ROBERT HAWES 4
4 · Cytosorbents Corp · Filed May 7, 2010
Insider Transaction Report
Form 4
BARTLETT ROBERT HAWES
Chief Medical Officer
Transactions
- Award
Stock Option
2010-05-05+900,000→ 1,125,000 totalExercise: $0.14From: 2010-05-05Exp: 2020-05-05→ Common Stock (900,000 underlying)